Skip NavigationSkip to Content

Synthesis and Biological Evaluation of 2-Acyl Analogues of Paclitaxel (Taxol)

  1. Author:
    Kingston, D. G. I.
    Chaudhary, A. G.
    Chordia, M. D.
    Gharpure, M.
    Gunatilaka, A. A. L.
    Higgs, P. I.
    Rimoldi, J. M.
    Samala, L.
    Jagtap, P. C.
    Giannakakou, P.
    Jiang, Y. Q.
    Lin, C. M.
    Hamel, E.
    Long, B. H.
    Fairchild, C. R.
    Johnston, K. A.
  2. Author Address

    Kingston DGI VIRGINIA POLYTECH INST & STATE UNIV DEPT CHEM BLACKSBURG, VA 24061 USA NCI DIV CLIN SCI MED BRANCH NIH BETHESDA, MD 20892 USA NCI FREDERICK CANC RES & DEV CTR DIV CANC TREATMENT & DIAG DEV THERAPEUT PROGRAM FREDERICK, MD 21702 USA BRISTOL MYERS SQUIBB PHARMACEUT RES INST PRINCETON, NJ USA
    1. Year: 1998
  1. Journal: Journal of Medicinal Chemistry
    1. 41
    2. 19
    3. Pages: 3715-3726
  2. Type of Article: Article
  1. Abstract:

    The anticancer drug paclitaxel (Taxol) has been converted to a large number of 2-debenzoyl-2-aroyl derivatives by three different methods. The bioactivities of the resulting analogues were determined in both tubulin polymerization and cytotoxicity assays, and several analogues with enhanced activity as compared with paclitaxel were discovered. Correlation of cytotoxicity in three cell lines with tubulin polymerization activity showed reasonable agreement. Among the cell lines examined, the closest correlation with antitubulin activity was observed with a human ovarian carcinoma cell line. [References: 53]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel